[go: up one dir, main page]

WO2019231128A1 - Vascular anastomosis device comprising biodegradable shape memory polymer film and stent - Google Patents

Vascular anastomosis device comprising biodegradable shape memory polymer film and stent Download PDF

Info

Publication number
WO2019231128A1
WO2019231128A1 PCT/KR2019/005564 KR2019005564W WO2019231128A1 WO 2019231128 A1 WO2019231128 A1 WO 2019231128A1 KR 2019005564 W KR2019005564 W KR 2019005564W WO 2019231128 A1 WO2019231128 A1 WO 2019231128A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood vessel
shape memory
memory polymer
stent
polymer film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2019/005564
Other languages
French (fr)
Korean (ko)
Inventor
장우순
허아람
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Future Biowokrs Co Ltd
Original Assignee
Future Biowokrs Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Future Biowokrs Co Ltd filed Critical Future Biowokrs Co Ltd
Publication of WO2019231128A1 publication Critical patent/WO2019231128A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/11Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00004(bio)absorbable, (bio)resorbable or resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/11Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/11Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1132End-to-end connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/16Materials with shape-memory or superelastic properties

Definitions

  • the present invention relates to a blood vessel anastomosis device including a biodegradable shape memory polymer film and a stent, and more particularly, by forming microneedles on one surface of the biodegradable shape memory polymer film, the microneedles are fixed to blood vessels while penetrating the outer wall of the blood vessel.
  • a blood vessel anastomosis device capable of preventing clot formation and occlusion of blood vessels.
  • vascular obstruction is gradually increasing, which narrows or substantially blocks the blood vessels of the human body.
  • most of the heart disease may be caused by ischemia that is blocked blood vessels that supply nutrition and oxygen to the heart, such as myocardial infarction, angina pectoris may correspond.
  • Surgical treatments can often be applied to treat such closed or nearly closed vessels.
  • a procedure may be used in which a site in which vascular occlusion has progressed is cut and then anastomated in the cut vessel.
  • vascular anastomosis surgery may be performed at the time of organ transplantation or anastomosis of the cut blood vessel.
  • the cross-section of the blood vessel is mainly composed of the inner layer (intima), the middle layer (media) and the outer layer (adventitia), and when the two vessels anastomosis, the inner layers are usually in close contact with the inner layers.
  • microsurgical surgeons use a suture to secure the surgical field of vision using a suture during reconstructive surgery or anastomosis of cut blood vessels. Since the method of suture by hand and manual is used, such suture surgery can be performed only by highly skilled doctors, and it takes a lot of time and effort to develop such specialists.
  • vascular anastomosis surgery by sutures requires the use of local flaps or free flaps for reconstruction after tissue removal surgery such as various cancer surgeries, and especially in the case of free flaps, micro anastomosis that connects blood vessels and blood vessels is essential.
  • tissue removal surgery such as various cancer surgeries
  • free flaps micro anastomosis that connects blood vessels and blood vessels is essential.
  • there is a problem such as an increase in the operation time, increase in cost, and the like.
  • Robert W. Mericle in US Pat. No. 4,214,586, provided the basic principle similar to US Pat. No. 3,774,615, but with a device for well-separating broken vessel ends.
  • the disadvantage of the anastomosis is not improved because the area where the disconnected portions of the blood vessels meet each other is still too small.
  • End-to-end vascular anastomosis surgery usually involves anastomosis of blood vessels with different diameters.
  • vascular anastomosis a uniform design is used for various types of vessel sizes and shapes for individual and surgical sites. There are many problems to use accordingly.
  • the surgical method uses a method of anastomizing blood vessels in a physical manner after fixing the blood vessels by eversion and fixing them to specific sites.
  • Physical anastomosis can be performed on veins with relatively thin muscle tissue of the vessel wall due to the characteristics of blood vessels, but it is difficult to use for arteries with thick muscle tissue of the vessel wall, especially in patients with vascular diseases.
  • the field of application is quite limited because the procedure cannot proceed.
  • vascular anastomosis is composed of substances that remain semi-permanently in the human body. Therefore, when a growing patient undergoes the procedure, it is necessary to suppress the growth of blood vessels and to perform repetitive vasodilation after a certain period of time. I have a problem.
  • the vascular anastomosis device which is inserted into the blood vessel and performs vascular anastomosis has the advantage of being naturally decomposed and removed after a certain time because it is made of biodegradable polymer, but the blood is coagulated due to the polymer inserted into the blood vessel.
  • the vascular endothelial cells are additionally generated due to the inserted vascular anastomosis device, thereby inducing excessive proliferation of smooth muscle cells inside the blood vessel, thereby causing narrowing of blood vessels.
  • Patent Document 1 U.S. Patent No. 4,214,586 (Name: Anastomotic coupling device, Registered Date: July 29, 1980)
  • Patent Document 2 US Patent No. 4,917,087 (Name: Anastomosis devices, kits and method, Registered date: April 17, 1990)
  • the present inventors can utilize various types of blood vessels according to various types of individual and surgical sites, and can easily perform anastomosis, biodegradable shape memory polymer film and stent.
  • a blood vessel anastomosis device has been invented that can be decomposed into the body after a certain period of time without additional device removal surgery and at the same time prevent the narrowing of blood vessels caused by anastomosis.
  • a blood vessel anastomosis device comprising a biodegradable shape memory polymer film and a stent.
  • the blood vessel anastomosis device comprises a biodegradable shape memory polymer film and stent, wherein the biodegradable shape memory polymer film has a plurality of micro-needle (micro-needle) on one surface It is formed, the stent has a shape that can be inserted into the blood vessel is made of a shape memory polymer.
  • the biodegradable shape memory polymer film has a plurality of micro-needle (micro-needle) on one surface It is formed, the stent has a shape that can be inserted into the blood vessel is made of a shape memory polymer.
  • the biodegradable shape memory polymer film may be a polymer material whose shape is modified according to temperature change.
  • the biodegradable shape memory polymer film may cover the outer wall of the blood vessel to prevent the separation of the blood vessel bonded.
  • the biodegradable shape memory polymer film may have holes formed therein.
  • the diameter of the hole may be 10 to 1000 ⁇ m.
  • the stent may be made of a shape memory polymer using temperature rise as an energy source of deformation, and may be deformed into an original shape, a temporary shape, or a permanent shape.
  • the stent may be biodegradable.
  • the vascular anastomosis device uses a biodegradable material, so that the device is decomposed in the body over time and does not require additional surgery to remove the device, thereby increasing the convenience of surgery and a better effect on the health of the patient. It can have
  • the blood vessel anastomosis device includes a biodegradable shape memory polymer film formed on one surface of the microneedle, thereby connecting the blood vessels cut using the microneedle and preventing the blood vessels from being detached, and the microneedle vessel
  • a biodegradable shape memory polymer film formed on one surface of the microneedle, thereby connecting the blood vessels cut using the microneedle and preventing the blood vessels from being detached, and the microneedle vessel
  • the blood vessel anastomosis device includes a stent, thereby maintaining the structure of the blood vessel by applying the stent inside the blood vessel.
  • the blood vessel anastomosis device includes a biodegradable shape memory polymer film and a stent, thereby maximizing the cross-sectional area of the blood vessel to be bonded to increase the bonding force, it is possible to achieve a stable vessel bonding.
  • FIG 1 and 2 are a cross-sectional view and a front view of the blood vessel anastomosis device according to one embodiment of the present invention applied to blood vessels.
  • FIGS. 3 and 4 are cross-sectional views and plan views of the biodegradable shape memory polymer film shown in FIGS. 1 and 2.
  • FIGS. 5 and 6 are views showing the expected intravascular reaction process after applying the blood vessel anastomosis device shown in FIGS. 1 and 2 to the blood vessel.
  • FIGS. 7 to 10 are views schematically illustrating a process in which the blood vessel anastomosis device shown in FIGS. 1 and 2 is inserted between the cut blood vessels and thus the blood vessel anastomosis is performed.
  • FIG. 1 and 2 is a view showing a blood vessel anastomosis device according to an embodiment of the present invention to blood vessels, Figure 1 is a cross-sectional view, Figure 2 is a front view.
  • the blood vessel anastomosis device includes a biodegradable shape memory polymer film 10 and a stent 30 to connect both ends of the cut blood vessel 20.
  • the shape memory referred to in the present invention refers to a property in which a processed object is broken or changed in shape, and when a certain condition is satisfied, the original shape is stored and returned.
  • biodegradability refers to a property in which an object decomposes over time in a chemical environment.
  • FIGS. 3 and 4 are cross-sectional views and plan views of the biodegradable shape memory polymer film shown in FIGS. 1 and 2.
  • the biodegradable shape memory polymer film 10 is made of a film form, has a flexibility can be transformed into a shape that covers the outer wall surrounding the vessel.
  • biodegradable shape memory polymer film 10 is to connect the cut blood vessels to surround the blood vessel outer wall with the biodegradable shape memory polymer film 10 and to fix it in this state (micro-needle) (10a) Penetrate the outer wall of the vessel with) to fix the vessels in the bonded state.
  • the biodegradable shape memory polymer film 10 may have a plurality of microneedles 10a formed on one surface thereof, and specifically, the biodegradable shape memory polymer film 10 is wrapped around the blood vessel outer periphery. As a result, the microneedle 10a penetrates the outer wall of the blood vessel and is firmly fixed to the outer peripheral edge of the blood vessel.
  • the microneedle 10a may be artificially damaged by penetrating the outer wall of the blood vessel. Artificial damage of the microneedle (10a) can prevent the closing of the blood vessels caused by narrowing the inner diameter of the blood vessels due to excessive proliferation of blood clots and smooth muscle cells generated when the stent is inserted into the blood vessels Has an effect. 5 and 6, which illustrate the expected intravascular reaction process after applying the blood vessel anastomosis device shown in FIGS. 1 and 2 to the blood vessel, for more detailed description.
  • the stent 30 when the stent 30 is inserted into a blood vessel, vascular endothelial cells are damaged to cause abnormal proliferation of smooth muscle cells, thereby increasing the thickness of the inner wall of the blood vessel and causing vascular narrowing.
  • the biodegradable shape memory polymer film 10 having the microneedle 10a according to the present invention along the outer circumference of the blood vessel as shown in FIG. 6, the microneedle 10a penetrates the outer wall of the blood vessel to insert the stent 30. Due to the abnormal growth of smooth muscle cells can control the direction of cell migration to the outer vessel wall.
  • the microneedle 10a wounds the outer wall of the blood vessel and artificially induces the movement of the smooth muscle cell to the outside of the blood vessel, thereby inhibiting excessive proliferation of thrombus and smooth muscle cells generated when inserted into the blood vessel, thereby narrowing the inner diameter of the blood vessel. It has the effect of preventing the occlusion of blood vessels that occur.
  • the microneedle (10a) is a biodegradable polymer material that is decomposed in the human body over time and absorbed by the human body, for example, poly (L-lactide) (PLLA), poly (D, L -lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycolide) (PLLA / PGA), poly (D, L-lactide-co-glycolide) (PLA / PGA), poly (glycolide cotrimethylene carbonate) (PGA / PTMC), polydioxanone (PDS), Polycaprolactone (PCL) , Polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), poly (glycolide-co-caprolactone) (PGA / PCL
  • the number, length, angle, and pattern of the microneedle 10a may be set in various ways according to the respective cases required for vascular anastomosis, and the number, length, angle, and pattern of the microneedle 10a may be changed as needed. Of course, it can be set.
  • the biodegradable shape memory polymer film 10 is a polymer material whose shape is changed according to temperature change, and is a polyester-based polymer, polyphosphazenes, polyanhydrides, polyacetals, poly (ortho esters), polyphosphoesters, polyglycolide, Poly ( ⁇ -caprolactone), polyurethanes, polylactide, polycarbonates, polyamides can be selected from one or a combination thereof, and the polymer exhibiting the shape memory function by the moisture, a hydroxyl group (-OH functional group) Hydrogel-based polymers including polyvinyl alcohol (PVA), chitosan (chitosan), or polyethylene glycol (PEG) may be used.
  • PVA polyvinyl alcohol
  • chitosan chitosan
  • PEG polyethylene glycol
  • the transition temperature is preferably 39 °C to 55 °C.
  • the biodegradable shape memory polymer film 10 has a function of exerting a shape memory function by temperature, thereby giving an external deformation of a blood vessel anastomosis device rather than a physical deformation of blood vessels, thereby allowing blood flow to occur according to physical deformation of blood vessels.
  • the shape can be modified to an appropriate size according to the inner diameter of each blood vessel, so that various types of individual and surgical parts Can be used depending on the size and shape of the vessel.
  • the biodegradable shape memory polymer film 10 is made of a biodegradable polymer that is biodegradable and decomposed over time in the human body.
  • the biodegradable polymer include poly (L-lactide) (PLLA) and poly (D, L-lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycol) Ride) (PLLA / PGA), Poly (D, L-lactide-co-glycolide) (PLA / PGA), Poly (glycolide cotrimethylene carbonate) (PGA / PTMC), Polydioxanone (PDS), Polycaprolactone (PCL), polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), polycoglycolide-co-caprolactone (
  • the biodegradable shape memory polymer film 10 has biodegradability, thereby inhibiting the growth of blood vessels when the growth stage patient is subjected to a procedure using a vascular anastomosis device composed of substances that remain semi-permanently in the human body. After a certain period of time can be solved the problem of proceeding repetitive vasodilation, and additional surgery to remove the device is not necessary because it increases the convenience of surgery and can have a better effect on the health of the patient.
  • the biodegradable shape memory polymer film 10 is made of a film form, it can be easily applied in utilizing in various types of blood vessel size and shape.
  • the thickness of the biodegradable shape memory polymer film 10 is 100 to 1000 ⁇ m, preferably 300 to 700 ⁇ m, more preferably 450 to 550 ⁇ m. If the thickness within the range is used, it is easy to apply to blood vessels of various sizes and shapes. In addition, by controlling the thickness of the biodegradable shape memory polymer film 10 can be adjusted to maintain the time in the body and to control the mechanical strength.
  • the biodegradable shape memory polymer film 10 may be formed with a hole (10b), the physical motion of the blood vessel by wrapping the blood vessel outer wall of the biodegradable shape memory polymer film (10) Since the blood vessel self-renewal ability can be reduced, the biodegradable shape memory polymer film 10 has an effect of maintaining the regeneration ability of blood vessels by forming holes 10b.
  • the diameter of the hole (10b) may be 10 to 1000 ⁇ m, preferably 100 to 300 ⁇ m, more preferably 150 to 250 ⁇ m, but is not limited thereto.
  • the stent 30 has a shape that can be inserted into a blood vessel and may be made of a shape memory polymer.
  • the shape memory polymer means using the temperature rise as the energy source of the shape deformation.
  • the stent 30 may be made of a shape memory polymer to be deformed into an original shape, a temporary shape, or a permanent shape.
  • the stent 30 made of the shape memory polymer according to the present invention is deformed sequentially into a circular stent 30, a temporary stent 30, a permanent stent 30.
  • the circular stent 30 is elongated when mechanical force is applied to both sides at the transition temperature of the shape memory polymer in a circular shape immediately after being manufactured, and thus the outer diameter is reduced. Is transformed into).
  • the temporary stent 30 of the deformed form is fixed to the stent 30 of the temporary form when the temperature is gradually reduced, and again applied to a temperature above the transition temperature of the shape-memory polymer stent of the temporary form that was transformed into mechanical energy ( 30 is to be transformed into a permanent stent (30).
  • the stent 30 is made of a shape memory polymer, the flexibility is high, so the shape is easily deformed according to the movement of the bronchus, and thus the stability after the procedure is high.
  • the stent 30 may be manufactured according to the size and shape of blood vessels, and may be modified to fit the size and shape of blood vessels after the procedure, thereby allowing a custom procedure that is suitable for each patient's blood vessels.
  • the stent 30 may be manufactured by restoring the original shape of the blood vessel and adjusting it to a physical strength that can be fixed in response to fluidly changing blood vessel internal pressure, thereby reducing the pressure applied to the inner wall of the blood vessel.
  • the stent 30 is made of a shape memory polymer, the stent 30 is restored to its own shape by body temperature after being inserted into the lumen, thereby simplifying the procedure and greatly shortening the overall procedure time.
  • shape memory polymer poly-norbornene, poly-isoprene, styrene-butadiene copolymer, polyurethane (poly-urethane), polyethylene (poly-ethylene)
  • polyester-based shape memory polymers include polyphosphazene, polyanhydride, polyacetal, poly-ortho ester, polyphosphoester and polyglycol.
  • polyglycolide poly- ⁇ -caprolactone
  • polylactide polycarbonate, polyamide
  • polyamide polyamide
  • poly (glycerol-sebacate) -stearate) or polycaprolactone-glycidyl methacrylate Poly (caprolactone-glycidylmethacrylate) that is easy to deform in consideration of the vascular internal environment. )] Can be used as a shape memory polymer.
  • the stent 30 may be biodegradable, and may be made of a biodegradable polymer that is decomposed and absorbed over time in the human body.
  • biodegradable polymer examples include poly (L-lactide) (PLLA) and poly (D).
  • L-lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycolide) (PLLA / PGA), poly (D, L-lactide-co-glycolide) (PLA / PGA), poly (glycolide cotrimethylene carbonate) (PGA / PTMC), polydioxanone (PDS), Polycaprolactone ( PCL), polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), polycoglycolide-co-caprolactone (PGA / PCL) and copolymers thereof It can be selected and used in one or a combination of these.
  • the stent 30 may be a mesh-like structure, and by having a mesh-like structure, the stent 30 may minimize a blood clot generated by insertion into the blood vessel.
  • the mesh structure means that a network shape is formed so that a plurality of holes are formed.
  • the stent 30 is elongated to extend the stent 30 to a temporary shape. After transformation into the vessel 20 is inserted. Then, while gradually increasing the temperature while maintaining the stent 30 temporary form (wherein the increased temperature is increased to a temperature of about 20 ⁇ 40 °C), the stent 30 is fixed in a temporary form, As shown in FIG. 9, heat is applied again to a temperature above the transition temperature, so that the stent 30 is restored to an initial circular shape before being deformed by mechanical force to maintain a permanent shape. Accordingly, the first cut blood vessels are anastomated and fixed so as not to reduce the inner diameter of the blood vessels.
  • the microdegradable microneedle 10a may be elongated by applying mechanical force to both sides of the biodegradable shape-memory polymer film 10 having an initial shape (transition temperature) at or below a transition temperature. ) Is transformed into a temporary shape by wrapping the outer wall of the blood vessel 20 so as to contact the outer wall of the blood vessel 20.
  • the microneedle (10a) of the biodegradable shape memory polymer film 10 passes through the outer wall of the vessel 20, while the biodegradable shape memory polymer film 10 is fixed to the vessel 20, the temporary form
  • the biodegradable shape memory polymer film 10 is fixed in a temporary form, and again the temperature above the transition temperature
  • the biodegradable shape memory polymer film 10 is restored to an initial circular shape before being deformed by mechanical force to maintain a permanent shape.
  • secondary vascular anastomosis is achieved to achieve excellent and stable vascular anastomosis.
  • the biodegradable shape memory polymer film 10 as one band for bonding the two vessels
  • the biodegradable shape memory polymer film 10 is deformed to cover the outer wall of the blood vessel and fixed in the temporary form, and then the temperature is raised to a temperature higher than the transition temperature so that the biodegradable shape memory
  • the polymer film 10 is contracted to reduce its outer diameter, and the outer circumferential surface of the biodegradable shape memory polymer film 10 is adhered to the cut outer wall of the blood vessel to be fixed in the permanent form, thereby achieving vascular anastomosis.
  • Vascular anastomosis device includes the biodegradable shape memory polymer film 10 and the stent 30 together, thereby maximizing the cross-sectional area of the blood vessel to be bonded to increase the bonding force, it is possible to achieve a stable blood vessel junction.
  • the present invention relates to a blood vessel anastomosis device including a biodegradable shape memory polymer film and a stent, and more particularly, by forming microneedles on one surface of the biodegradable shape memory polymer film, the microneedles are fixed to blood vessels while penetrating the outer wall of the blood vessel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a vascular anastomosis device comprising a biodegradable shape memory polymer film and a stent, and more specifically, by forming microneedles on one side of the biodegradable shape memory polymer film, the microneedles penetrate the outer wall of a blood vessel and become fixed to the blood vessel, connecting a disconnected blood vessel, and at the same time, inserting the stent into the disconnected blood vessel to maintain the structure of the connected blood vessel, so that thrombus formation and blockage of the blood vessel, which occur as the internal diameter of the blood vessel becomes narrower due to excessive proliferation of smooth muscle cells inside the blood vessel after the blood vessel is connected, can be prevented.

Description

생분해성 형상기억 고분자 필름 및 스텐트를 포함하는 혈관 문합 장치Vascular anastomosis device including biodegradable shape memory polymer film and stent

본 발명은 생분해성 형상기억 고분자 필름 및 스텐트를 포함하는 혈관 문합 장치에 관한 것으로 더욱 상세하게는 생분해성 형상기억 고분자 필름 일면에 마이크로니들을 형성함으로써, 상기 마이크로니들이 혈관 외벽을 뚫으면서 혈관에 고정되어 절단된 혈관을 연결하고, 동시에 절단된 혈관 내부에 스텐트를 삽입하여 접합된 혈관의 구조를 유지함으로써, 혈관이 문합되고 혈관 내부에 평활근 세포(Smooth muscle cell)가 과다 증식하여 혈관의 내경이 좁아지면서 발생하는 혈전 형성 및 혈관의 폐쇄를 방지할 수 있는 혈관 문합 장치에 관한 것이다.The present invention relates to a blood vessel anastomosis device including a biodegradable shape memory polymer film and a stent, and more particularly, by forming microneedles on one surface of the biodegradable shape memory polymer film, the microneedles are fixed to blood vessels while penetrating the outer wall of the blood vessel. By connecting the cut blood vessels and simultaneously inserting a stent into the cut blood vessels to maintain the structure of the blood vessels, the blood vessels are anastomated and smooth muscle cells are excessively proliferated in the blood vessels, thereby narrowing the inner diameter of the blood vessels. The present invention relates to a blood vessel anastomosis device capable of preventing clot formation and occlusion of blood vessels.

급격하게 도시화가 진행되고, 사람들의 운동 부족, 식습관의 서구화 등이 만연해짐에 따라 인체의 혈관이 좁아지거나 상당 부분 막히는 이른바, 혈관 폐쇄 질환이 점차 증가하고 있다. 특히, 심장 질환의 대부분은 심장에 영양과 산소를 공급하는 혈관이 막히는 허혈증(ischemia)에 의해 나타날 수 있는데, 대표적으로 심근 경색, 협심증 등이 이에 해당할 수 있다.As urbanization rapidly progresses and people's lack of exercise and eating habits become more widespread, so-called vascular obstruction is gradually increasing, which narrows or substantially blocks the blood vessels of the human body. In particular, most of the heart disease may be caused by ischemia that is blocked blood vessels that supply nutrition and oxygen to the heart, such as myocardial infarction, angina pectoris may correspond.

이러한 폐쇄 혈관, 또는 거의 폐쇄된 혈관을 치료하기 위해서는 종종 수술 치료법이 적용될 수 있다. 예를 들어, 혈관 폐쇄가 진행된 부위를 잘라낸 다음, 잘라진 혈관을 문합하는 시술법이 사용될 수 있다. 또한, 이러한 혈관 폐쇄 질환의 치료뿐만 아니라, 장기이식술(organ Transplantation)이나, 절단된 혈관의 문합 수술 시에도 혈관 문합 수술이 수행될 수 있다.Surgical treatments can often be applied to treat such closed or nearly closed vessels. For example, a procedure may be used in which a site in which vascular occlusion has progressed is cut and then anastomated in the cut vessel. In addition to the treatment of such vascular obstruction, vascular anastomosis surgery may be performed at the time of organ transplantation or anastomosis of the cut blood vessel.

혈관의 단면은 주로 내층(intima), 중간층(media) 및 외층(adventitia)으로 구성되어 있으며, 두 혈관을 문합할 경우에 내층은 내층끼리 밀착시켜 문합하는 경우가 일반적이다.The cross-section of the blood vessel is mainly composed of the inner layer (intima), the middle layer (media) and the outer layer (adventitia), and when the two vessels anastomosis, the inner layers are usually in close contact with the inner layers.

상기와 같은 심장의 혈관폐쇄질환의 치료뿐만 아니라 피판이전수술에 의한 재건수술이나 절단된 혈관의 문합 수술 시에 미세수술 전문의사가 직접 봉합사(suture)를 사용하여 현미경이나 고배율 확대경으로 수술 시야를 확보하고 수작업(manual)에 의해 일일이 봉합하는 방법이 사용되고 있기 때문에 이러한 봉합수술은 고도로 숙련된 전문의사에 의해서만 시행될 수 있고, 이러한 전문가를 육성하기 위해서는 많은 시간과 노력을 필요로 한다.In addition to the treatment of vascular obstruction of the heart as described above, microsurgical surgeons use a suture to secure the surgical field of vision using a suture during reconstructive surgery or anastomosis of cut blood vessels. Since the method of suture by hand and manual is used, such suture surgery can be performed only by highly skilled doctors, and it takes a lot of time and effort to develop such specialists.

또한, 이러한 봉합사에 의한 혈관 문합 수술문합 수술은 각종 암 수술 등 조직 제거 수술 후 재건을 위해서 local flap이나 자유피판을 이용해야 하며, 특히 자유피판의 경우 혈관과 혈관을 이어주는 미세문합술을 필수적으로 시행해야 하기에, 이로 인한 수술시간의 증가, 비용의 증가 등이 문제가 된다.In addition, the vascular anastomosis surgery by sutures requires the use of local flaps or free flaps for reconstruction after tissue removal surgery such as various cancer surgeries, and especially in the case of free flaps, micro anastomosis that connects blood vessels and blood vessels is essential. In the following, there is a problem such as an increase in the operation time, increase in cost, and the like.

따라서 이러한 봉합사(suture)를 사용하여 일일이 손으로 혈관을 직접 봉합하는 것을 피하기 위해 다수의 혈관 문합 장치들이 고안되었다. 그 중, 혈관의 단부 대 단부 방식의 문합을 용이하게 시행할 수 있도록 하는 장치로 미국특허 제3,774,615호, 미국특허 제4,214,586호 및 미국특허 제4,917,087호 등이 있고, 이미 상품화되어 있는 예로는 미국 Synovis Micro Companies Alliance사의 미세혈관 문합용 커플러(microvascular anastomotic coupler)가 있다.Therefore, a number of vascular anastomosis devices have been devised to avoid suturing blood vessels directly by hand using such sutures. Among them, US Pat. No. 3,774,615, US Pat. No. 4,214,586, and US Pat. No. 4,917,087 are examples of devices that can easily perform end-to-end anastomosis of blood vessels, and US Synovis is already commercialized. There is a microvascular anastomotic coupler from the Micro Companies Alliance.

림(Drahoslav Lim) 외 2명은 미국특허 제3,774,615호에서 단절된 혈관을 수술하지 않고 문합하는 장치를 제시하였는데, 이 장치는 혈관이 문합되는 부위에서 혈관들을 완전히 고정시키지 않고, 절단된 두 혈관 주변들을 돌아가면서 골고루 접착시키는 것이 쉽지 않으며, 단절된 부분이 서로 만나는 부위의 면적이 너무 작기 때문에 문합이 제대로 이루어지지 않고 혈액이 샐 가능성이 있다.Drahoslav Lim and two others presented a device for anastomosis without surgery in a broken blood vessel in US Pat. No. 3,774,615, which does not completely fix the vessels at the site where the vessels are anastomated, but turns around the two cut vessels. It is not easy to glue evenly along the way, and because the area where the disconnected parts meet each other is too small, the anastomosis may not work properly and blood may leak.

메리클(Robert W. Mericle)은 미국특허 제4,214,586호에서 그 기본원리는 미국특허 제3,774,615호와 흡사하지만 단절된 혈관 끝 부위들을 잘 고정 시키는 장치를 마련하였다. 하지만, 혈관의 단절된 부분이 서로 만나는 부위의 면적이 여전히 너무 작아서 문합이 제대로 이루어지지 않는 단점은 향상되지 않았다.Robert W. Mericle, in US Pat. No. 4,214,586, provided the basic principle similar to US Pat. No. 3,774,615, but with a device for well-separating broken vessel ends. However, the disadvantage of the anastomosis is not improved because the area where the disconnected portions of the blood vessels meet each other is still too small.

월쉬(David J. Walsh) 외 3명은 미국특허 제4,917,087호에서 고정된 관 모양(tubular shape)으로 된 혈관 문합 장치를 제시하였는데 이 장치는 단부 대 단부(end-to-end) 또는 단부 대 측부(end-to-side) 문합에 사용할 수는 있지만 두 혈관의 직경이 같은 경우에만 사용할 수 있으며, 내층과 내층의 문합 후 내층부분과 관련 고정하는 힘이 약하여 문합 전으로 되돌아 오려는 경향이 있기 때문에 효율적이지 못하다.David J. Walsh and three others presented a fixed tubular vascular anastomosis device in US Pat. No. 4,917,087, which is an end-to-end or end-to-side ( It can be used for end-to-side anastomosis, but can only be used if the two vessels have the same diameter, and it is efficient because it has a tendency to return to the anastomosis because of the weak fixing force associated with the inner layer after anastomosis of the inner and inner layers. Can not do it.

단부 대 단부 혈관 문합 수술은 서로 다른 크기의 직경을 갖는 혈관들을 문합하는 경우가 대부분인데, 기존의 혈관 문합기를 사용하는 경우, 획일적인 디자인으로 개인별, 시술부위별로 다양한 종류의 혈관 크기 및 모양에 따라 활용하기에는 많은 문제점들을 보이고 있다.End-to-end vascular anastomosis surgery usually involves anastomosis of blood vessels with different diameters. In the case of using conventional vascular anastomosis, a uniform design is used for various types of vessel sizes and shapes for individual and surgical sites. There are many problems to use accordingly.

또한, 상술한 바와 같은 대부분의 기존 혈관 문합기들의 경우, 시술방법이 혈관을 외번(eversion)하여 특정부위에 고정한 후 물리적인 방식으로 혈관을 문합하는 방식을 이용하고 있는데, 이러한 혈관의 외번을 통한 물리적 문합 방법은 혈관의 특성상 비교적 혈관벽의 근육조직이 얇은 정맥에는 시술이 가능하지만 상대적으로 혈관벽의 근육조직이 두꺼운 동맥에는 사용이 어려운 문제점이 있으며, 특히 혈관질환이 있는 환자에게는 이러한 물리적 혈관 외번을 통한 시술을 진행할 수 없기 때문에 그 활용분야가 상당히 제한적이다.In addition, in the case of most existing vascular anastomosis apparatus as described above, the surgical method uses a method of anastomizing blood vessels in a physical manner after fixing the blood vessels by eversion and fixing them to specific sites. Physical anastomosis can be performed on veins with relatively thin muscle tissue of the vessel wall due to the characteristics of blood vessels, but it is difficult to use for arteries with thick muscle tissue of the vessel wall, especially in patients with vascular diseases. The field of application is quite limited because the procedure cannot proceed.

이 뿐만 아니라, 대부분의 혈관 문합기들이 인체 내에서 반영구적으로 잔존하는 물질들로 구성되어 있어, 성장기 환자가 시술을 받을 경우 혈관의 성장을 억제하여 일정시간이 경과 후 반복적인 혈관 확장술을 진행해야 한다는 문제점을 안고 있다.In addition, most vascular anastomosis is composed of substances that remain semi-permanently in the human body. Therefore, when a growing patient undergoes the procedure, it is necessary to suppress the growth of blood vessels and to perform repetitive vasodilation after a certain period of time. I have a problem.

또한, 혈관 외부에 장착되어 혈관 문합술을 수행하는 혈관 문합 장치의 경우에는 혈관이 단절되어 서로 만나는 부위의 면적이 너무 작아 문합이 제대로 이루어지지 않아 혈액이 유출되는 문제점이 있다. 또한 추후에 장치를 제거하는 수술을 진행해야 하는 단점이 있다.In addition, in the case of a blood vessel anastomosis device mounted on the outside of the blood vessel to perform an anastomosis, blood vessels may be disconnected so that the area of the anastomosis is too small so that anastomosis may not be properly performed and blood may leak. In addition, there is a disadvantage in that the surgery to remove the device in the future.

반면, 혈관 내부에 삽입하여 혈관 문합술을 수행하는 혈관 문합 장치의 경우, 생분해성 고분자로 이루어져 있어 일정 시간이 흐른 후 자연스레 분해되어 제거되는 장점을 가지나, 혈관 내부에 삽입된 고분자로 인해 혈액이 응고되는 현상이 발생하고, 삽입된 혈관 문합 장치로 인해 추가 발생된 혈관 내피세포의 손상으로 혈관 내부에 평활근 세포(Smooth muscle cell)의 과다 증식을 유도하여 혈관의 협착이 일어나는 문제점이 있다.On the other hand, the vascular anastomosis device which is inserted into the blood vessel and performs vascular anastomosis has the advantage of being naturally decomposed and removed after a certain time because it is made of biodegradable polymer, but the blood is coagulated due to the polymer inserted into the blood vessel. In this case, the vascular endothelial cells are additionally generated due to the inserted vascular anastomosis device, thereby inducing excessive proliferation of smooth muscle cells inside the blood vessel, thereby causing narrowing of blood vessels.

[선행기술문헌][Preceding technical literature]

[특허문헌][Patent Documents]

(특허문헌 1) 미국등록특허 제4,214,586호(명칭: Anastomotic coupling device, 등록일: 1980.07.29)(Patent Document 1) U.S. Patent No. 4,214,586 (Name: Anastomotic coupling device, Registered Date: July 29, 1980)

(특허문헌 2) 미국등록특허 제4,917,087호(명칭: Anastomosis devices, kits and method, 등록일: 1990.04.17)(Patent Document 2) US Patent No. 4,917,087 (Name: Anastomosis devices, kits and method, Registered date: April 17, 1990)

본 발명자들은 상기와 같은 문제점을 해결하기 위하여, 다양한 개인별, 시술부위별로 다양한 종류의 혈관 크기 및 모양에 따라 활용이 가능하고, 문합술 과정이 매우 간편하게 수행할 수 있으며, 생분해성 형상기억 고분자 필름 및 스텐트를 이용함으로써 일정 시간이 지난 후 체내에 분해되어 추가 장치제거수술이 필요치 않으면서, 동시에 문합술에 따라 발생되는 혈관의 협착을 방지할 수 있는 혈관 문합 장치를 발명하였다.In order to solve the above problems, the present inventors can utilize various types of blood vessels according to various types of individual and surgical sites, and can easily perform anastomosis, biodegradable shape memory polymer film and stent. By using the present invention, a blood vessel anastomosis device has been invented that can be decomposed into the body after a certain period of time without additional device removal surgery and at the same time prevent the narrowing of blood vessels caused by anastomosis.

따라서, 본 발명의 목적은 생분해성 형상기억 고분자 필름 및 스텐트를 포함하는 혈관 문합 장치를 제공하는 것이다.Accordingly, it is an object of the present invention to provide a blood vessel anastomosis device comprising a biodegradable shape memory polymer film and a stent.

상기 목적을 달성하기 위해, 본 발명의 일 실시예에 따른 혈관 문합 장치는 생분해성 형상기억 고분자 필름 및 스텐트를 포함하되, 상기 생분해성 형상기억 고분자 필름은 일면에 복수개의 마이크로니들(micro-needle)이 형성되고, 상기 스텐트는 혈관 내로 삽입될 수 있는 형상을 가지며 형상기억 고분자로 제조된 것이다.In order to achieve the above object, the blood vessel anastomosis device according to an embodiment of the present invention comprises a biodegradable shape memory polymer film and stent, wherein the biodegradable shape memory polymer film has a plurality of micro-needle (micro-needle) on one surface It is formed, the stent has a shape that can be inserted into the blood vessel is made of a shape memory polymer.

상기 생분해성 형상기억 고분자 필름은 온도 변화에 따라 형태가 변형되는 고분자 물질일 수 있다. 또한, 상기 생분해성 형상기억 고분자 필름은 접합된 혈관의 이탈을 방지하기 위해 혈관의 외벽을 감싸 커버할 수 있다. The biodegradable shape memory polymer film may be a polymer material whose shape is modified according to temperature change. In addition, the biodegradable shape memory polymer film may cover the outer wall of the blood vessel to prevent the separation of the blood vessel bonded.

상기 생분해성 형상기억 고분자 필름은 홀이 형성되어 있을 수 있다. 여기서, 상기 홀의 직경은 10 내지 1000㎛일 수 있다.The biodegradable shape memory polymer film may have holes formed therein. Here, the diameter of the hole may be 10 to 1000㎛.

상기 스텐트는 온도 상승을 형태변형의 에너지원으로 이용하는 형상기억 고분자로 제조되어 원형(original shape), 임시형태(temporary shape), 또는 영구형태(permanent shape)로 변형될 수 있다. 또한, 상기 스텐트는 생분해성일 수 있다.The stent may be made of a shape memory polymer using temperature rise as an energy source of deformation, and may be deformed into an original shape, a temporary shape, or a permanent shape. In addition, the stent may be biodegradable.

본 발명에 따른 혈관 문합 장치는 생분해성 소재를 사용함으로써 장치가 일정 시간이 지남에 따라 체내에서 분해되어 장치를 제거하기 위한 추가적인 수술이 필요 없으므로 수술 편의성을 증대하는 것은 물론 환자의 건강 측면에서도 나은 효과를 가질 수 있다.The vascular anastomosis device according to the present invention uses a biodegradable material, so that the device is decomposed in the body over time and does not require additional surgery to remove the device, thereby increasing the convenience of surgery and a better effect on the health of the patient. It can have

또한 본 발명에 따른 혈관 문합 장치는 마이크로니들이 일면에 형성된 생분해성 형상기억 고분자 필름을 포함함으로써, 마이크로니들을 이용하여 절단된 혈관을 연결하고 접합된 혈관이 이탈되는 것을 방지할 수 있으며, 마이크로니들이 혈관의 외벽을 통과하여 인위적인 손상을 일으킴으로써 혈관 내부에 평활근 세포(Smooth muscle cell)의 과다 증식으로 인한 혈관의 내경이 좁아지면서 발생하는 혈전 형성 및 혈관의 폐쇄를 방지할 수 있다.In addition, the blood vessel anastomosis device according to the present invention includes a biodegradable shape memory polymer film formed on one surface of the microneedle, thereby connecting the blood vessels cut using the microneedle and preventing the blood vessels from being detached, and the microneedle vessel By causing artificial damage through the outer wall of the blood vessels due to the excessive growth of the smooth muscle cells (Smooth muscle cells) due to the narrowing of the inner diameter of the blood vessels can be prevented clot formation and blood vessel closure.

또한 본 발명에 따른 혈관 문합 장치는 스텐트를 포함함으로써, 상기 스텐트를 혈관 내부에 적용하여 혈관의 구조체를 유지시킬 수 있다.In addition, the blood vessel anastomosis device according to the present invention includes a stent, thereby maintaining the structure of the blood vessel by applying the stent inside the blood vessel.

또한 본 발명에 따른 혈관 문합 장치는 생분해성 형상기억 고분자 필름 및 스텐트를 함께 포함함으로써, 접합하고자 하는 혈관의 단면적을 최대화하여 접합력을 높이고, 안정된 상태의 혈관 접합을 이룰 수 있다.In addition, the blood vessel anastomosis device according to the present invention includes a biodegradable shape memory polymer film and a stent, thereby maximizing the cross-sectional area of the blood vessel to be bonded to increase the bonding force, it is possible to achieve a stable vessel bonding.

도 1 및 도 2는 본 발명의 일실시예에 따른 혈관 문합 장치를 혈관에 적용한 도면으로, 단면도 및 정면도이다.1 and 2 are a cross-sectional view and a front view of the blood vessel anastomosis device according to one embodiment of the present invention applied to blood vessels.

도 3 및 도 4는 도 1 및 도 2에 도시된 생분해성 형상기억 고분자 필름의 단면도 및 평면도이다.3 and 4 are cross-sectional views and plan views of the biodegradable shape memory polymer film shown in FIGS. 1 and 2.

도 5 및 도 6은 도 1 및 도 2에 도시된 혈관 문합 장치를 혈관에 적용한 후 예상되는 혈관 내 반응과정을 나타낸 도면이다.5 and 6 are views showing the expected intravascular reaction process after applying the blood vessel anastomosis device shown in FIGS. 1 and 2 to the blood vessel.

도 7 내지 도 10은 도 1 및 도 2에 도시된 혈관 문합 장치가 절단된 혈관 사이에 삽입되어 혈관 문합이 이루어지는 과정을 개략적으로 보여주는 도면이다.7 to 10 are views schematically illustrating a process in which the blood vessel anastomosis device shown in FIGS. 1 and 2 is inserted between the cut blood vessels and thus the blood vessel anastomosis is performed.

이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시 예에 대하여 첨부한 도면을 참고로 하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다. 명세서 전체를 통하여 유사한 부분에 대해서는 동일한 도면 부호를 붙였다.Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art may easily implement the present invention. As those skilled in the art would realize, the described embodiments may be modified in various different ways, all without departing from the spirit or scope of the present invention. Like parts are designated by like reference numerals throughout the specification.

도 1 및 도 2는 본 발명의 일실시예에 따른 혈관 문합 장치를 혈관에 적용한 도면으로, 도 1은 단면도이고, 도 2는 정면도이다.1 and 2 is a view showing a blood vessel anastomosis device according to an embodiment of the present invention to blood vessels, Figure 1 is a cross-sectional view, Figure 2 is a front view.

도 1 및 도 2를 참조하면, 본 발명에 따른 혈관 문합 장치는 절단된 혈관(20)의 양쪽 단부를 연결하기 위해 생분해성 형상기억 고분자 필름(10) 및 스텐트(30)를 포함한다.1 and 2, the blood vessel anastomosis device according to the present invention includes a biodegradable shape memory polymer film 10 and a stent 30 to connect both ends of the cut blood vessel 20.

본 발명에서 언급하는 형상기억이란, 가공된 물체가 망가지거나 모양이 변했다가 어떤 조건을 만족하게 되면 원래의 형상을 기억해내어 되돌아 가는 성질을 의미한다. The shape memory referred to in the present invention refers to a property in which a processed object is broken or changed in shape, and when a certain condition is satisfied, the original shape is stored and returned.

본 발명에서 언급하는 생분해성이란, 체내 환경에서 화학적으로 일정 시간이 지남에 따라 물체가 분해되는 성질을 의미한다.As used herein, the term "biodegradability" refers to a property in which an object decomposes over time in a chemical environment.

도 3 및 도 4는 도 1 및 도 2에 도시된 생분해성 형상기억 고분자 필름의 단면도 및 평면도이다.3 and 4 are cross-sectional views and plan views of the biodegradable shape memory polymer film shown in FIGS. 1 and 2.

도 3 및 도 4와 같이, 상기 생분해성 형상기억 고분자 필름(10)은 필름형태로 이루어져 있으며, 유연성을 가지고 있어 혈관 외벽을 감싸 커버하는 형상으로 변형이 가능하다. As shown in Figure 3 and 4, the biodegradable shape memory polymer film 10 is made of a film form, has a flexibility can be transformed into a shape that covers the outer wall surrounding the vessel.

또한, 상기 생분해성 형상기억 고분자 필름(10)은 절단된 혈관을 연결시키기 위한 것으로 혈관 외벽을 생분해성 형상기억 고분자 필름(10)으로 둘러싸고 이 상태로 고정하기 위해 마이크로니들(micro-needle)(10a)로 혈관 외벽을 뚫어 혈관이 접합된 상태로 고정시킨다.In addition, the biodegradable shape memory polymer film 10 is to connect the cut blood vessels to surround the blood vessel outer wall with the biodegradable shape memory polymer film 10 and to fix it in this state (micro-needle) (10a) Penetrate the outer wall of the vessel with) to fix the vessels in the bonded state.

좀 더 구체적으로, 상기 생분해성 형상기억 고분자 필름(10)은 일면에 복수개의 마이크로니들(10a)이 형성될 수 있으며, 구체적으로 상기 생분해성 형상기억 고분자 필름(10)을 혈관 외주연부를 따라 감쌈으로써 마이크로니들(10a)이 혈관 외벽을 뚫고 들어가 혈관 외주연부에 견고하게 고정된다. More specifically, the biodegradable shape memory polymer film 10 may have a plurality of microneedles 10a formed on one surface thereof, and specifically, the biodegradable shape memory polymer film 10 is wrapped around the blood vessel outer periphery. As a result, the microneedle 10a penetrates the outer wall of the blood vessel and is firmly fixed to the outer peripheral edge of the blood vessel.

또한, 상기 마이크로니들(10a)은 앞서 서술한 바와 같이, 혈관 외벽을 뚫고 들어감으로써 인위적인 손상을 입힐 수 있다. 이러한 마이크로니들(10a)의 인위적인 손상은 상기 스텐트를 혈관 내부에 삽입시 발생되는 혈전 및 평활근 세포(Smooth muscle cell)의 과다 증식에 의해 혈관의 내경이 좁아지면서 발생하는 혈관의 폐쇄를 방지할 수 있는 효과를 가진다. 좀더 자세한 설명을 위하여 도 5 및 도 6을 참조하면, 도 5 및 도 6은 도 1 및 도 2에 도시된 혈관 문합 장치를 혈관에 적용한 후 예상되는 혈관 내 반응과정을 나타낸 도면이다.In addition, as described above, the microneedle 10a may be artificially damaged by penetrating the outer wall of the blood vessel. Artificial damage of the microneedle (10a) can prevent the closing of the blood vessels caused by narrowing the inner diameter of the blood vessels due to excessive proliferation of blood clots and smooth muscle cells generated when the stent is inserted into the blood vessels Has an effect. 5 and 6, which illustrate the expected intravascular reaction process after applying the blood vessel anastomosis device shown in FIGS. 1 and 2 to the blood vessel, for more detailed description.

도 5와 같이 일반적으로 스텐트(30)가 혈관 내부에 삽입될 경우 혈관 내피세포가 손상을 입어 평활근 세포의 이상증식을 일으키게 되고 이에 따라 혈관 내벽의 두께가 두꺼워지면서 혈관 협착을 발생하게 된다. 반면에 도 6과 같이 혈관 외주연부를 따라 본 발명에 따른 마이크로니들(10a)이 형성된 생분해성 형상기억 고분자 필름(10)을 감쌈으로써, 마이크로니들(10a)이 혈관 외벽을 뚫어 스텐트(30) 삽입으로 인해 이상증식된 평활근 세포를 혈관외벽으로 세포이동의 방향을 조절할 수 있다. 즉, 마이크로니들(10a)이 혈관 외벽에 상처를 내어 평활근 세포의 이동을 인위적으로 혈관 외부로 유도함으로써, 혈관 내부에 삽입시 발생되는 혈전 및 평활근 세포의 과다 증식을 억제하여 혈관의 내경이 좁아지면서 발생하는 혈관의 폐쇄를 방지할 수 있는 효과를 가진다.Generally, as shown in FIG. 5, when the stent 30 is inserted into a blood vessel, vascular endothelial cells are damaged to cause abnormal proliferation of smooth muscle cells, thereby increasing the thickness of the inner wall of the blood vessel and causing vascular narrowing. On the other hand, by wrapping the biodegradable shape memory polymer film 10 having the microneedle 10a according to the present invention along the outer circumference of the blood vessel as shown in FIG. 6, the microneedle 10a penetrates the outer wall of the blood vessel to insert the stent 30. Due to the abnormal growth of smooth muscle cells can control the direction of cell migration to the outer vessel wall. That is, the microneedle 10a wounds the outer wall of the blood vessel and artificially induces the movement of the smooth muscle cell to the outside of the blood vessel, thereby inhibiting excessive proliferation of thrombus and smooth muscle cells generated when inserted into the blood vessel, thereby narrowing the inner diameter of the blood vessel. It has the effect of preventing the occlusion of blood vessels that occur.

또한, 상기 마이크로니들(10a)은 생분해성을 가지며 시간 경과에 따라 인체 내에서 분해되어 인체에 흡수되는 고분자 물질로서, 예를 들어, 폴리(L-락타이드)(PLLA), 폴리(D,L-lactide)(PLA), 폴리(글리콜리드)(PGA), 폴리(L-lactide-co-D,L-lactide)(PLLA/PLA), 폴리(l-락타이드-코-글리콜라이드)(PLLA/PGA), 폴리(D,L-lactide-co-glycolide)(PLA/PGA), 폴리(글라이콜라이드 코 트라이메틸렌 카보네이트)(PGA/PTMC), 폴리디옥사논 (PDS), Polycaprolactone(PCL), 폴리하이드록시부티레이트(PHBT), 폴리(포스파젠)폴리(D,Llactide-co-caprolactone)PLA/PCL), 폴리(glycolide-co-caprolactone)(PGA/PCL) 및 이들의 공중합체 중 하나 또는 이들의 조합에서 선택하여 사용할 수 있다.In addition, the microneedle (10a) is a biodegradable polymer material that is decomposed in the human body over time and absorbed by the human body, for example, poly (L-lactide) (PLLA), poly (D, L -lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycolide) (PLLA / PGA), poly (D, L-lactide-co-glycolide) (PLA / PGA), poly (glycolide cotrimethylene carbonate) (PGA / PTMC), polydioxanone (PDS), Polycaprolactone (PCL) , Polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), poly (glycolide-co-caprolactone) (PGA / PCL) and copolymers thereof or It can select from these combinations, and can use.

여기서, 상기 마이크로니들(10a)의 개수, 길이, 각도 및 패턴은 혈관 문합술에 필요한 각각의 경우에 따라 다양하게 설정할 수 있으며, 필요에 따라 마이크로니들(10a)의 개수, 길이, 각도 및 패턴을 달리 설정할 수 있음은 물론이다.Here, the number, length, angle, and pattern of the microneedle 10a may be set in various ways according to the respective cases required for vascular anastomosis, and the number, length, angle, and pattern of the microneedle 10a may be changed as needed. Of course, it can be set.

상기 생분해성 형상기억 고분자 필름(10)은 온도 변화에 따라 형태가 변형되는 고분자 물질로, 폴리에스터(polyester) 계열의 고분자들로써, Polyphosphazenes, polyanhydrides, polyacetals, poly(ortho ester)s, polyphosphoesters, polyglycolide, poly(ε-caprolactone), polyurethanes, polylactide, polycarbonates, polyamides 중 하나 또는 이들의 조합에서 선택하여 사용할 수 있으며, 상기 수분에 의해 형상기억 기능을 발휘하는 고분자로는, 하이드록시기(-OH functional group)를 다수 포함하고 있는 PVA(Polyvinyl alcohol), 키토산(chitosan) 또는 PEG(Polyethylene glycol)등을 포함하는 하이드로겔(hydrogel) 기반의 고분자가 사용될 수 있다.The biodegradable shape memory polymer film 10 is a polymer material whose shape is changed according to temperature change, and is a polyester-based polymer, polyphosphazenes, polyanhydrides, polyacetals, poly (ortho esters), polyphosphoesters, polyglycolide, Poly (ε-caprolactone), polyurethanes, polylactide, polycarbonates, polyamides can be selected from one or a combination thereof, and the polymer exhibiting the shape memory function by the moisture, a hydroxyl group (-OH functional group) Hydrogel-based polymers including polyvinyl alcohol (PVA), chitosan (chitosan), or polyethylene glycol (PEG) may be used.

이때, 상기 생분해성 형상기억 고분자 필름(10)의 전이온도는 39℃ 내지 55℃ 인 것이 바람직하다.At this time, the biodegradable shape memory polymer film 10, the transition temperature is preferably 39 ℃ to 55 ℃.

즉, 상기 생분해성 형상기억 고분자 필름(10)은 온도에 의해 형상기억 기능을 발휘하는 기능을 가짐으로써, 혈관의 물리적 변형이 아닌 혈관 문합 장치의 외형적 변형을 주어 혈관의 물리적 변형에 따른 혈류 흐름에 악영향을 줄 수 있는 여러 원인들을 최소화시키고, 서로 다른 모양 및 크기의 혈관을 문합하는 경우에도 각각의 혈관의 내경에 따라 적절한 크기로 형태를 변형할 수 있어, 다양한 개인별, 시술부위별로 다양한 종류의 혈관 크기 및 모양에 따라 활용이 가능하다.That is, the biodegradable shape memory polymer film 10 has a function of exerting a shape memory function by temperature, thereby giving an external deformation of a blood vessel anastomosis device rather than a physical deformation of blood vessels, thereby allowing blood flow to occur according to physical deformation of blood vessels. Minimize the various causes that can adversely affect the anastomosis, and even when anastomosis of blood vessels of different shapes and sizes, the shape can be modified to an appropriate size according to the inner diameter of each blood vessel, so that various types of individual and surgical parts Can be used depending on the size and shape of the vessel.

상기 생분해성 형상기억 고분자 필름(10)은 생분해성으로 인체 내에서 시간 경과에 따라 분해되어 흡수되는 생분해성 고분자로 이루어져 있으며, 생분해성 고분자의 예로, 폴리(L-락타이드)(PLLA), 폴리(D,L-lactide)(PLA), 폴리(글리콜리드)(PGA), 폴리(L-lactide-co-D,L-lactide)(PLLA/PLA), 폴리(l-락타이드-코-글리콜라이드)(PLLA/PGA), 폴리(D,L-lactide-co-glycolide)(PLA/PGA), 폴리(글라이콜라이드 코 트라이메틸렌 카보네이트)(PGA/PTMC), 폴리디옥사논 (PDS), Polycaprolactone(PCL), 폴리하이드록시부티레이트(PHBT), 폴리(포스파젠)폴리(D,Llactide-co-caprolactone)PLA/PCL), 폴리(glycolide-co-caprolactone)(PGA/PCL) 및 이들의 공중합체 중 하나 또는 이들의 조합에서 선택하여 사용할 수 있다.The biodegradable shape memory polymer film 10 is made of a biodegradable polymer that is biodegradable and decomposed over time in the human body. Examples of the biodegradable polymer include poly (L-lactide) (PLLA) and poly (D, L-lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycol) Ride) (PLLA / PGA), Poly (D, L-lactide-co-glycolide) (PLA / PGA), Poly (glycolide cotrimethylene carbonate) (PGA / PTMC), Polydioxanone (PDS), Polycaprolactone (PCL), polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), polycoglycolide-co-caprolactone (PGA / PCL) and their aerials It can be selected and used in one or a combination thereof.

이와 같이, 상기 생분해성 형상기억 고분자 필름(10)은 생분해성을 가짐으로써, 성장기 환자가 인체 내에서 반영구적으로 잔존하는 물질들로 구성된 혈관 문합 장치를 이용하여 시술을 받는 경우 혈관의 성장을 억제하여 일정시간이 경과 후 반복적인 혈관 확장술을 진행해야 하는 문제점을 해결할 수 있고, 장치를 제거하기 위한 추가적인 수술이 필요 없으므로 수술 편의성을 증대하는 것은 물론 환자의 건강 측면에서도 나은 효과를 가질 수 있다.As described above, the biodegradable shape memory polymer film 10 has biodegradability, thereby inhibiting the growth of blood vessels when the growth stage patient is subjected to a procedure using a vascular anastomosis device composed of substances that remain semi-permanently in the human body. After a certain period of time can be solved the problem of proceeding repetitive vasodilation, and additional surgery to remove the device is not necessary because it increases the convenience of surgery and can have a better effect on the health of the patient.

상기 생분해성 형상기억 고분자 필름(10)은 필름형태로 이루어져 있어, 다양한 종류의 혈관 크기 및 모양에 활용함에 있어 용이하게 적용이 가능하다.The biodegradable shape memory polymer film 10 is made of a film form, it can be easily applied in utilizing in various types of blood vessel size and shape.

이때, 상기 생분해성 형상기억 고분자 필름(10)의 두께는 100 내지 1000㎛이며, 바람직하게는 300 내지 700㎛이며, 더욱 바람직하게는 450 내지 550㎛이다. 해당 범위 내의 두께를 사용할 경우 다양한 크기 및 모양의 혈관에 적용함에 있어 용이성이 높다. 또한, 상기 생분해성 형상기억 고분자 필름(10)의 두께를 조절하여 체내에 유지되는 시간을 조절할 수 있으며 기계적 강도를 조절할 수 있다.At this time, the thickness of the biodegradable shape memory polymer film 10 is 100 to 1000㎛, preferably 300 to 700㎛, more preferably 450 to 550㎛. If the thickness within the range is used, it is easy to apply to blood vessels of various sizes and shapes. In addition, by controlling the thickness of the biodegradable shape memory polymer film 10 can be adjusted to maintain the time in the body and to control the mechanical strength.

상기 도 3 및 도 4와 같이, 상기 생분해성 형상기억 고분자 필름(10)은 홀(10b)이 형성될 수 있으며, 상기 생분해성 형상기억 고분자 필름(10)을 혈관 외벽을 감쌈으로써 혈관의 물리적 운동이 저하되어 혈관 자가 재생능력이 감소할 수 있으므로, 상기 생분해성 형상기억 고분자 필름(10)은 홀(10b)을 형성함으로써, 혈관의 재생능력을 유지시키는 효과를 가진다.3 and 4, the biodegradable shape memory polymer film 10 may be formed with a hole (10b), the physical motion of the blood vessel by wrapping the blood vessel outer wall of the biodegradable shape memory polymer film (10) Since the blood vessel self-renewal ability can be reduced, the biodegradable shape memory polymer film 10 has an effect of maintaining the regeneration ability of blood vessels by forming holes 10b.

이때, 상기 홀(10b)의 직경은 10 내지 1000㎛ 일 수 있으며, 바람직하게는 100 내지 300㎛이며, 더욱 바람직하게는 150 내지 250㎛이나, 이에 제한되지 않는다.In this case, the diameter of the hole (10b) may be 10 to 1000㎛, preferably 100 to 300㎛, more preferably 150 to 250㎛, but is not limited thereto.

상기 스텐트(30)는 혈관 내로 삽입될 수 있는 형상을 가지며 형상기억 고분자로 제조될 수 있다. 이때, 상기 형상기억 고분자는 온도 상승을 형태변형의 에너지원으로 이용하는 것을 의미한다.The stent 30 has a shape that can be inserted into a blood vessel and may be made of a shape memory polymer. In this case, the shape memory polymer means using the temperature rise as the energy source of the shape deformation.

또한, 상기 스텐트(30)는 형상기억 고분자로 제조되어 원형(original shape), 임시형태(temporary shape), 또는 영구형태(permanent shape)로 변형될 수 있다. In addition, the stent 30 may be made of a shape memory polymer to be deformed into an original shape, a temporary shape, or a permanent shape.

본 발명에 따른 형상기억 고분자로 제조된 스텐트(30)는 원형의 스텐트(30), 임시형태의 스텐트(30), 영구형태의 스텐트(30)로 순차적으로 변형된다. The stent 30 made of the shape memory polymer according to the present invention is deformed sequentially into a circular stent 30, a temporary stent 30, a permanent stent 30.

더 상세하게 원형의 스텐트(30)는 제작된 직후의 원형에서 형상기억 고분자의 전이온도(transition temperature) 이상에서 양쪽으로 기계적 힘이 가해지면 연신(elongation)되어 외경이 감소되는 임시형태의 스텐트(30)로 변형된다. In more detail, the circular stent 30 is elongated when mechanical force is applied to both sides at the transition temperature of the shape memory polymer in a circular shape immediately after being manufactured, and thus the outer diameter is reduced. Is transformed into).

그리고, 변형된 임시형태의 스텐트(30)는 서서히 온도를 감소시키면 임시형태의 스텐트(30)로 고정되고, 다시 형상기억 고분자의 전이온도 이상의 온도를 가해주면 기계적 에너지로 변형되었던 임시형태의 스텐트(30)는 영구형태의 스텐트(30)로 변형되게 된다.And, the temporary stent 30 of the deformed form is fixed to the stent 30 of the temporary form when the temperature is gradually reduced, and again applied to a temperature above the transition temperature of the shape-memory polymer stent of the temporary form that was transformed into mechanical energy ( 30 is to be transformed into a permanent stent (30).

상기 스텐트(30)가 형상기억 고분자로 제조되어 유연성(flexibility)이 높아 기관지의 움직임에 맞추어 형태가 변형되기 쉬워 시술 후 안정감이 높다. Since the stent 30 is made of a shape memory polymer, the flexibility is high, so the shape is easily deformed according to the movement of the bronchus, and thus the stability after the procedure is high.

상기 스텐트(30)는 혈관의 크기와 형태에 맞게 제조될 수 있고, 시술 후 혈관의 크기와 형태에 맞게 변형되어 각 환자의 혈관에 맞는 맞춤 시술을 가능하게 한다. The stent 30 may be manufactured according to the size and shape of blood vessels, and may be modified to fit the size and shape of blood vessels after the procedure, thereby allowing a custom procedure that is suitable for each patient's blood vessels.

상기 스텐트(30)는 혈관의 본래 형태를 복원하고 유동적으로 변화하는 혈관 내부 압력에 저항하여 고정될 수 있는 물리적 강도로 조절하여 제조될 수 있고, 이로써 혈관 내벽에 가해지는 압박을 줄일 수 있다.The stent 30 may be manufactured by restoring the original shape of the blood vessel and adjusting it to a physical strength that can be fixed in response to fluidly changing blood vessel internal pressure, thereby reducing the pressure applied to the inner wall of the blood vessel.

상기 스텐트(30)는 형상기억 고분자로 제조됨으로써, 스텐트(30)가 내강 내부에 삽입 후 체온에 의해 스스로 원형으로 복원되어 시술이 간편하여 전체 시술시간을 대폭 단축시키게 된다. 이때, 형상기억 고분자의 예로, 폴리노르보넨(poly-norbornene), 폴리이소프렌(poly-isoprene), 스티렌-부타디엔 공중합체(Styrene-butadiene copolymer), 폴리우레탄(Poly-urethane), 폴리에틸렌(Poly-ethylene), 폴리에스터(polyester) 계열의 고분자를 포함하나 이에 한정되는 것은 아니다. 폴리에스터 계열의 형상기억 고분자의 예로는 폴리포스파젠(Polyphosphazene), 폴리무수물산(polyanhydride), 폴리아세탈(polyacetal), 폴리오쏘에스터(poly-ortho ester), 폴리인산디에스테르(polyphosphoester), 폴리글리콜리드(polyglycolide), 폴리카프로락톤(poly-ε-caprolactone), 폴리락타이드(polylactide), 폴리카보네이트(polycarbonate), 폴리아미드(polyamide) 중 하나 또는 이들의 조합으로 선택될 수 있으나, 이에 한정되는 것은 아니다. 바람직하게는 혈관 내부 환경을 고려하여 형상 변형이 용이한 폴리글리세롤-세바스산염-스테아레이트[Poly(glycerol-sebacate)-stearate] 또는 폴리카프로락톤-글리시딜메타크릴레이트[Poly(caprolactone-glycidylmethacrylate)]을 형상기억 고분자로 사용할 수 있다.Since the stent 30 is made of a shape memory polymer, the stent 30 is restored to its own shape by body temperature after being inserted into the lumen, thereby simplifying the procedure and greatly shortening the overall procedure time. In this case, as an example of the shape memory polymer, poly-norbornene, poly-isoprene, styrene-butadiene copolymer, polyurethane (poly-urethane), polyethylene (poly-ethylene) ), But is not limited to polyester (polyester) polymer. Examples of polyester-based shape memory polymers include polyphosphazene, polyanhydride, polyacetal, poly-ortho ester, polyphosphoester and polyglycol. It may be selected from one or a combination of polyglycolide, poly-ε-caprolactone, polylactide, polycarbonate, polyamide, but is not limited thereto. no. Preferably, poly (glycerol-sebacate) -stearate] or polycaprolactone-glycidyl methacrylate [Poly (caprolactone-glycidylmethacrylate) that is easy to deform in consideration of the vascular internal environment. )] Can be used as a shape memory polymer.

상기 스텐트(30)는 생분해성일 수 있으며, 인체 내에서 시간 경과에 따라 분해되어 흡수되는 생분해성 고분자로 이루어질 수 있으며, 생분해성 고분자의 예로, 폴리(L-락타이드)(PLLA), 폴리(D,L-lactide)(PLA), 폴리(글리콜리드)(PGA), 폴리(L-lactide-co-D,L-lactide)(PLLA/PLA), 폴리(l-락타이드-코-글리콜라이드)(PLLA/PGA), 폴리(D,L-lactide-co-glycolide)(PLA/PGA), 폴리(글라이콜라이드 코 트라이메틸렌 카보네이트)(PGA/PTMC), 폴리디옥사논 (PDS), Polycaprolactone(PCL), 폴리하이드록시부티레이트(PHBT), 폴리(포스파젠)폴리(D,Llactide-co-caprolactone)PLA/PCL), 폴리(glycolide-co-caprolactone)(PGA/PCL) 및 이들의 공중합체 중 하나 또는 이들의 조합에서 선택하여 사용할 수 있다.The stent 30 may be biodegradable, and may be made of a biodegradable polymer that is decomposed and absorbed over time in the human body. Examples of the biodegradable polymer include poly (L-lactide) (PLLA) and poly (D). , L-lactide) (PLA), poly (glycolide) (PGA), poly (L-lactide-co-D, L-lactide) (PLLA / PLA), poly (l-lactide-co-glycolide) (PLLA / PGA), poly (D, L-lactide-co-glycolide) (PLA / PGA), poly (glycolide cotrimethylene carbonate) (PGA / PTMC), polydioxanone (PDS), Polycaprolactone ( PCL), polyhydroxybutyrate (PHBT), poly (phosphazene) poly (D, Llactide-co-caprolactone) PLA / PCL), polycoglycolide-co-caprolactone (PGA / PCL) and copolymers thereof It can be selected and used in one or a combination of these.

상기 스텐트(30)는 메쉬형 구조체일 수 있으며, 메쉬형 구조를 가짐으로써 스텐트(30)가 혈관내 삽입되어 발생되는 혈전을 최소화할 수 있다. The stent 30 may be a mesh-like structure, and by having a mesh-like structure, the stent 30 may minimize a blood clot generated by insertion into the blood vessel.

이때, 메쉬형 구조체란 복수개의 구멍이 형성되도록 망(network) 형상을 형성시킨 것을 의미한다.In this case, the mesh structure means that a network shape is formed so that a plurality of holes are formed.

이하에서는 본 발명의 일 실시예에 따른 혈관 문합 장치의 형태 변화 과정 및 본 발명에 따른 혈관 문합 장치를 이용하여 혈관 문합이 이루어지는 과정에 대해 도 7 내지 도 10을 참조하여 간략하게 설명하기로 한다.Hereinafter, a process of changing the shape of the vascular anastomosis device according to an embodiment of the present invention and a process of vascular anastomosis using the vascular anastomosis device according to the present invention will be briefly described with reference to FIGS. 7 to 10.

먼저 초기 원형 형태(original shape)의 스텐트(30)를 절단된 혈관(20) 내부에 삽입하기 위해, 도 8과 같이, 스텐트(30)를 길게 연장시켜 스텐트(30)를 임시 형태(temporary shape)로 변형시킨 후 혈관(20) 내부에 삽입한다. 그 다음, 스텐트(30) 임시 형태를 유지하면서 서서히 온도를 증가시키면(여기서, 증가되는 온도는 대략 20~40℃ 정도의 온도까지 증가시킨다.), 상기 스텐트(30)은 임시 형태로 고정되고, 도 9와 같이, 다시 전이온도 이상의 온도가 되도록 열을 가해주어, 상기 스텐트(30)은 기계적 힘에 의해 변형되기 전의 초기 원형 형태로 복원되어 영구 형태(permanent shape)를 유지하게 된다. 이에 따라, 1차적으로 절단된 혈관을 문합시키고 혈관의 내경이 축소되지 않도록 고정되게 된다. First, in order to insert the stent 30 of the initial circular shape (original shape) into the cut blood vessel 20, as shown in FIG. 8, the stent 30 is elongated to extend the stent 30 to a temporary shape. After transformation into the vessel 20 is inserted. Then, while gradually increasing the temperature while maintaining the stent 30 temporary form (wherein the increased temperature is increased to a temperature of about 20 ~ 40 ℃), the stent 30 is fixed in a temporary form, As shown in FIG. 9, heat is applied again to a temperature above the transition temperature, so that the stent 30 is restored to an initial circular shape before being deformed by mechanical force to maintain a permanent shape. Accordingly, the first cut blood vessels are anastomated and fixed so as not to reduce the inner diameter of the blood vessels.

다음으로, 도 10과 같이, 초기 원형 형태(original shape)의 상기 생분해성 형상기억 고분자 필름(10)을 전이온도(transition temperature) 이하에서 양쪽으로 기계적 힘을 가해 연신(elongation)시켜 마이크로니들(10a)이 혈관(20) 외벽에 접하도록 혈관(20) 외벽을 감쌈으로써 임시 형태(temporary shape)로 변형시킨다.Next, as shown in FIG. 10, the microdegradable microneedle 10a may be elongated by applying mechanical force to both sides of the biodegradable shape-memory polymer film 10 having an initial shape (transition temperature) at or below a transition temperature. ) Is transformed into a temporary shape by wrapping the outer wall of the blood vessel 20 so as to contact the outer wall of the blood vessel 20.

이때, 상기 생분해성 형상기억 고분자 필름(10)의 마이크로니들(10a)이 혈관(20) 외벽을 통과하여 상기 생분해성 형상기억 고분자 필름(10)이 혈관(20)에 고정된 채로, 임시 형태를 유지하면서 서서히 온도를 증가시키면(여기서, 증가되는 온도는 대략 20~40℃ 정도의 온도까지 증가시킨다), 상기 생분해성 형상기억 고분자 필름(10)은 임시 형태로 고정되고, 다시 전이온도 이상의 온도가 되도록 열을 가해주면, 상기 생분해성 형상기억 고분자 필름(10)은 기계적 힘에 의해 변형되기 전의 초기 원형 형태로 복원되어 영구 형태(permanent shape)를 유지하게 된다. 이에 따라, 2차적으로 혈관 문합이 이루어져 접합력이 우수하고 안정된 혈관 문합을 이루게 된다.At this time, the microneedle (10a) of the biodegradable shape memory polymer film 10 passes through the outer wall of the vessel 20, while the biodegradable shape memory polymer film 10 is fixed to the vessel 20, the temporary form By gradually increasing the temperature while maintaining (wherein the increased temperature is increased to a temperature of about 20 ~ 40 ℃), the biodegradable shape memory polymer film 10 is fixed in a temporary form, and again the temperature above the transition temperature When the heat is applied, the biodegradable shape memory polymer film 10 is restored to an initial circular shape before being deformed by mechanical force to maintain a permanent shape. As a result, secondary vascular anastomosis is achieved to achieve excellent and stable vascular anastomosis.

즉, 절단된 두 혈관사이에서 각각의 혈관 내부에 스텐트(30)를 삽입하여 혈관 내경이 축소되지 않도록 고정하고, 두 혈관이 접합하기 위한 하나의 밴드처럼 상기 생분해성 형상기억 고분자 필름(10)을 양쪽으로 기계적 힘을 가해 연신 시킴으로써, 혈관 외벽을 감싸도록 변형하여 상기 생분해성 형상기억 고분자 필름(10)을 상기 임시 형태로 고정시킨 후, 전이온도 이상의 온도가 되도록 온도를 상승시켜 상기 생분해성 형상기억 고분자 필름(10)이 수축되어 그 외경을 축소되어, 상기 생분해성 형상기억 고분자 필름(10)의 외주면이 상기 절단된 혈관 외벽에 밀착되어 상기 영구 형태로 고정됨으로써, 혈관 문합이 이루어지게 된다.That is, by inserting the stent 30 inside each vessel between the two vessels cut so as not to shrink the vessel diameter, the biodegradable shape memory polymer film 10 as one band for bonding the two vessels After stretching by applying mechanical force to both sides, the biodegradable shape memory polymer film 10 is deformed to cover the outer wall of the blood vessel and fixed in the temporary form, and then the temperature is raised to a temperature higher than the transition temperature so that the biodegradable shape memory The polymer film 10 is contracted to reduce its outer diameter, and the outer circumferential surface of the biodegradable shape memory polymer film 10 is adhered to the cut outer wall of the blood vessel to be fixed in the permanent form, thereby achieving vascular anastomosis.

본 발명에 따른 혈관 문합 장치는 생분해성 형상기억 고분자 필름(10) 및 스텐트(30)를 함께 포함함으로써, 접합하고자 하는 혈관의 단면적을 최대화하여 접합력을 높이고, 안정된 상태의 혈관 접합을 이룰 수 있다.Vascular anastomosis device according to the present invention includes the biodegradable shape memory polymer film 10 and the stent 30 together, thereby maximizing the cross-sectional area of the blood vessel to be bonded to increase the bonding force, it is possible to achieve a stable blood vessel junction.

이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although the preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements of those skilled in the art using the basic concepts of the present invention defined in the following claims are also provided. It belongs to the scope of rights.

[부호의 설명][Description of the code]

10 : 생분해성 형상기억 고분자 필름10: biodegradable shape memory polymer film

10a: 마이크로니들10a: microneedle

10b: 홀10b: hall

20 : 혈관20: blood vessel

30 : 스텐트30: stent

본 발명은 생분해성 형상기억 고분자 필름 및 스텐트를 포함하는 혈관 문합 장치에 관한 것으로 더욱 상세하게는 생분해성 형상기억 고분자 필름 일면에 마이크로니들을 형성함으로써, 상기 마이크로니들이 혈관 외벽을 뚫으면서 혈관에 고정되어 절단된 혈관을 연결하고, 동시에 절단된 혈관 내부에 스텐트를 삽입하여 접합된 혈관의 구조를 유지함으로써, 혈관이 문합되고 혈관 내부에 평활근 세포(Smooth muscle cell)가 과다 증식하여 혈관의 내경이 좁아지면서 발생하는 혈전 형성 및 혈관의 폐쇄를 방지할 수 있다.The present invention relates to a blood vessel anastomosis device including a biodegradable shape memory polymer film and a stent, and more particularly, by forming microneedles on one surface of the biodegradable shape memory polymer film, the microneedles are fixed to blood vessels while penetrating the outer wall of the blood vessel. By connecting the cut blood vessels and inserting a stent into the cut blood vessels at the same time to maintain the structure of the bonded blood vessels, the blood vessels are anastomated and smooth muscle cells are excessively proliferated in the blood vessels, thereby narrowing the inner diameter of the blood vessels. Thrombus formation and occlusion of blood vessels that occur may be prevented.

Claims (7)

절단된 혈관의 양쪽 단부를 연결하기 위한 혈관 문합 장치에 있어서,In the blood vessel anastomosis device for connecting both ends of the cut blood vessel, 상기 혈관 문합 장치는 생분해성 형상기억 고분자 필름 및 스텐트를 포함하되,The vascular anastomosis device includes a biodegradable shape memory polymer film and stent, 상기 생분해성 형상기억 고분자 필름은 일면에 복수개의 마이크로니들(micro-needle)이 형성되고,The biodegradable shape memory polymer film has a plurality of micro-needle (micro-needle) is formed on one surface, 상기 스텐트는 혈관 내로 삽입될 수 있는 형상을 가지며 형상기억 고분자로 제조된 것인 혈관 문합 장치.The stent has a shape that can be inserted into the blood vessel and a blood vessel anastomosis device that is made of a shape memory polymer. 제 1항에 있어서,The method of claim 1, 상기 생분해성 형상기억 고분자 필름은The biodegradable shape memory polymer film 온도 변화에 따라 형태가 변형되는 고분자 물질인 것을 특징으로 하는 혈관 문합 장치.Vascular anastomosis device, characterized in that the polymer material is deformed according to temperature changes. 제 1항에 있어서,The method of claim 1, 상기 생분해성 형상기억 고분자 필름은 접합된 혈관의 이탈을 방지하기 위해 혈관의 외벽을 감싸 커버하는 것을 특징으로 하는 혈관 문합 장치.The biodegradable shape memory polymer film is vascular anastomosis device, characterized in that to cover the outer wall of the blood vessel to prevent the separation of the blood vessels bonded. 제 1항에 있어서,The method of claim 1, 상기 생분해성 형상기억 고분자 필름은 홀이 형성되어 있는 것을 특징으로 하는 혈관 문합 장치.The biodegradable shape memory polymer film is vascular anastomosis device, characterized in that the hole is formed. 제 4항에 있어서, The method of claim 4, wherein 상기 홀의 직경은 10 내지 1000㎛인 것을 특징으로 하는 혈관 문합 장치.The diameter of the hole is a blood vessel anastomosis device, characterized in that 10 to 1000㎛. 제 1항에 있어서, The method of claim 1, 상기 스텐트는 온도 상승을 형태변형의 에너지원으로 이용하는 형상기억 고분자로 제조되어 원형(original shape), 임시형태(temporary shape), 또는 영구형태(permanent shape)로 변형될 수 있는 것을 특징으로 하는 혈관 문합 장치.The stent is made of a shape memory polymer that uses the temperature rise as an energy source of shape deformation, and thus can be transformed into an original shape, a temporary shape, or a permanent shape. Device. 제 1항에 있어서,The method of claim 1, 상기 스텐트는 생분해성인 것을 특징으로 하는 혈관 문합 장치.The stent is vascular anastomosis device, characterized in that the biodegradable.
PCT/KR2019/005564 2018-05-31 2019-05-09 Vascular anastomosis device comprising biodegradable shape memory polymer film and stent Ceased WO2019231128A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2018-0062649 2018-05-31
KR1020180062649A KR102224938B1 (en) 2018-05-31 2018-05-31 Vascular anastomosis device containing biodegradable shape memory polymer film and stent

Publications (1)

Publication Number Publication Date
WO2019231128A1 true WO2019231128A1 (en) 2019-12-05

Family

ID=68697007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/005564 Ceased WO2019231128A1 (en) 2018-05-31 2019-05-09 Vascular anastomosis device comprising biodegradable shape memory polymer film and stent

Country Status (2)

Country Link
KR (1) KR102224938B1 (en)
WO (1) WO2019231128A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113558696A (en) * 2021-07-08 2021-10-29 河南省人民医院 Blood vessel anastomat for kidney transplantation operation
CN113907915A (en) * 2021-09-27 2022-01-11 浙江大学 A suture-free coagulation-assisted fixation cardiac patch and preparation method thereof
CN115721445A (en) * 2022-12-12 2023-03-03 上海市第六人民医院 A tectorial membrane support for acute cerebral apoplexy vascular intervention treatment

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102385674B1 (en) * 2020-03-13 2022-04-12 건국대학교 산학협력단 A Composition for Inducing Anomalous Vessel Attenuation Comprising Punched Organic Polymer Films
KR102547679B1 (en) * 2023-02-07 2023-06-26 주식회사 티엠디랩 Shape-memory polymers with self-expandable and biofilm-reducing properties and use of the same as medical materials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080138378A1 (en) * 2002-07-11 2008-06-12 Kareen Looi Cell seeded expandable body
US20120277774A1 (en) * 2009-11-13 2012-11-01 The Brigham And Women's Hospital, Inc. Method and Apparatus for Vascular Anastomosis
KR101624488B1 (en) * 2016-01-22 2016-05-26 주식회사 퓨처바이오웍스 Vascular Anastomosis Device
KR101664009B1 (en) * 2015-02-26 2016-10-10 전북대학교산학협력단 Anti migration stent for non vascular and manufacturing method thereof
KR101748551B1 (en) * 2017-02-17 2017-06-16 주식회사 퓨처바이오웍스 Shape memory polymer based vascular anastomosis device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080138378A1 (en) * 2002-07-11 2008-06-12 Kareen Looi Cell seeded expandable body
US20120277774A1 (en) * 2009-11-13 2012-11-01 The Brigham And Women's Hospital, Inc. Method and Apparatus for Vascular Anastomosis
KR101664009B1 (en) * 2015-02-26 2016-10-10 전북대학교산학협력단 Anti migration stent for non vascular and manufacturing method thereof
KR101624488B1 (en) * 2016-01-22 2016-05-26 주식회사 퓨처바이오웍스 Vascular Anastomosis Device
KR101748551B1 (en) * 2017-02-17 2017-06-16 주식회사 퓨처바이오웍스 Shape memory polymer based vascular anastomosis device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113558696A (en) * 2021-07-08 2021-10-29 河南省人民医院 Blood vessel anastomat for kidney transplantation operation
CN113907915A (en) * 2021-09-27 2022-01-11 浙江大学 A suture-free coagulation-assisted fixation cardiac patch and preparation method thereof
CN113907915B (en) * 2021-09-27 2022-07-29 浙江大学 Suture-free blood coagulation auxiliary fixing heart patch and preparation method thereof
CN115721445A (en) * 2022-12-12 2023-03-03 上海市第六人民医院 A tectorial membrane support for acute cerebral apoplexy vascular intervention treatment

Also Published As

Publication number Publication date
KR102224938B1 (en) 2021-03-09
KR20190136658A (en) 2019-12-10

Similar Documents

Publication Publication Date Title
WO2019231128A1 (en) Vascular anastomosis device comprising biodegradable shape memory polymer film and stent
US7416546B2 (en) Tissue patches and related delivery systems and methods
US8545482B2 (en) Tissues patches and related delivery systems and methods
EP2389122B1 (en) Clip devices
JP2021142324A (en) Stent with dual tissue-wall anchoring mechanism
WO2018110999A1 (en) Automatic pancreaticojejunostomy stent
EP2863813B1 (en) Biodegradable blood vessel occlusion and narrowing
AU2021427747A1 (en) A compression anastomosis system, and use thereof
US10420661B2 (en) Stents and stent deployment devices
AU2013324023A1 (en) Temporary aids for deployment and fixation of tissue repair implants
US20080188787A1 (en) Device and method for nipple reconstruction
US20170281924A1 (en) Fibrotic band interrupter and implant introducing device
EP2615986B1 (en) Ligation device
WO2009049677A1 (en) Shape-changing medical device, kit, method of production and method of use
US20130274772A1 (en) Apparatuses and methods for anastomosis
KR101748551B1 (en) Shape memory polymer based vascular anastomosis device
WO2018199683A1 (en) Stent for anastomosis of different kinds of organs
EP4281133B1 (en) Medical implantable devices and methods of using the same
AU2022277552B2 (en) Lumen apposing stent to deliver targeted therapy
WO2020138670A1 (en) Stent comprising biodegradable polymer and nitinol, and manufacturing method therefor
WO2023129101A1 (en) Neural tube that increases nerve regeneration
US20250288451A1 (en) Artificial intestinal device and surgical method using the same
WO2019054565A1 (en) Biodegradable suture having retainers, and method for producing same
WO2020197262A1 (en) Fibrosis-inducing drug-eluting stent for blocking electric conduction
KR20210022399A (en) Vascular anastomosis device comprising water soluble polymer carrier

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19811851

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19811851

Country of ref document: EP

Kind code of ref document: A1